by Dan Roberts Originally published on MDSupport, updated March 2005 Since March 2000, an experimental study (“Transpupillary Thermotherapy of Occult Subfoveal Choroidal Neovascular Membrane,” or TTT4CNV”) has been underway using transpupillary thermotherapy (TTT) for the treatment of the occult form of age-related macular degeneration (AMD). The therapy utilizes a low dose of infrared laser light […]
by Dan Roberts (Updated March 10, 2005) Doctors reported successful results from analyses of Miravant Medical Technologies’ Phase III clinical trials for Photrex (aka rostaporfin or SnET2) on October 25, 2004 at the American Academy of Ophthalmology (AAO) meeting in New Orleans. Photrex is a proprietary photodynamic therapy drug which has been studied in two […]
by Dan Roberts March 2005 A research team at the University of California, San Diego (UCSD) School of Medicine and the University of Utah have developed a mouse model of Age-Related Macular Degeneration (AMD) and Stargardt’s disease. As reported in the online edition of the Proceedings of the National Academy of Sciences (March 4, 2005), […]